Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors

NCT07644650 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplams

Interventions

BIOLOGICAL: MST-168

Sponsor

Mabsoft Therapeutics (Shanghai) Co., Ltd.

Collaborators

[object Object]
[object Object]